Milestone Pharmaceuticals Inc.
MIST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $47 | $42 | $45 | $25 |
| Short-Term Investments | $36 | $1 | $11 | $44 |
| Receivables | $2 | $2 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $1 | $2 | $2 |
| Total Curr. Assets | $87 | $46 | $60 | $74 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $1 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $88 | $47 | $62 | $75 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $2 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $6 | $10 | $6 |
| Total Curr. Liab. | $11 | $9 | $13 | $8 |
| LT Debt | $57 | $56 | $55 | $54 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $57 | $56 | $55 | $54 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $67 | $65 | $68 | $62 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $312 | $288 | $288 | $288 |
| Retained Earnings | -$413 | -$401 | -$388 | -$368 |
| AOCI | $56 | $53 | $53 | $53 |
| Other Equity | $66 | $42 | $41 | $40 |
| Total Equity | $21 | -$18 | -$6 | $13 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $88 | $47 | $62 | $75 |
| Net Debt | $11 | $14 | $11 | $29 |